InvestSMART

Invex Therapeutics Ltd (ASX:IXC)

ALERT: Price-sensitive ASX Announcement for IXC
Current share price for IXC : $0.110 -0.005 (-4.35%)+
Release
7 Nov 2025 2:41PM
Price at Release
$0.115
Full Release
download
Summary
Invex Therapeutics Ltd, trading under the symbol IXC on the Australian Securities Exchange (ASX), has been suspended from official quotation. This action is due to the company not having enough directors to comply with section 201A(2) of the Corporations Act 2001 (Cth). The suspension will remain until the company satisfies ASX requirements, which include compliance with Listing Rule 12.5, ensuring that it is appropriate for its securities to resume trading.
Key Points
  • Invex Therapeutics Ltd's securities have been suspended.
  • Suspension is due to insufficient directors as per the Corporations Act 2001.
  • ASX requires compliance with Listing Rule 12.5 for reinstatement.
  • Suspension will continue until IXC meets ASX’s listing rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.